← back to search

Urvi Kapoor

Columbia University Irving Medical Center · US
🔎 Find collaborators in Hematology · Public Health, Environmental and Occupational Health →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, and Congenital Heart Disease Studies.
h-index
8
citations
550
works
24
NIH funding
primary concept
Medicine
email

Recent publications

A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Transplantation and Cellular Therapy 2024cited by 12position: middledoi
Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party
Journal of Clinical Immunology 2024cited by 8position: middledoi
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
Blood 2022cited by 42position: middledoi
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
Blood Advances 2022cited by 32position: middledoi
Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy
Blood 2022cited by 0position: middledoi
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Journal of Clinical Oncology 2021cited by 242position: middledoi
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation
Blood 2020cited by 35position: middledoi
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant
Leukemia 2020cited by 32position: middledoi
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Blood Advances 2019cited by 106position: middledoi
Comparison of Gvhd Biomarker Algorithms for Predicting Lethal Gvhd and Non-Relapse Mortality
Biology of Blood and Marrow Transplantation 2019cited by 5position: middledoi
Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease
Blood 2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Joseph H. Chewning · University of Alabama at Birmingham1 papers (2020–2020)Alan S. Wayne · University of Southern California1 papers (2020–2020)Gregory A. Yanik · Cincinnati Children's Hospital Medical Center1 papers (2020–2020)Mariam H Johnson · Medical College of Wisconsin1 papers (2020–2020)Kwang Woo Ahn · Medical College of Wisconsin1 papers (2020–2020)Michael R. Verneris · University of Colorado Anschutz Medical Campus1 papers (2020–2020)Brandon M. Triplett · Oak Ridge National Laboratory1 papers (2020–2020)Nirali N. Shah · National Institutes of Health1 papers (2020–2020) · 1 papers (2020–2020)Muna Qayed · Winship Cancer Institute1 papers (2020–2020)Mary Eapen · Medical College of Wisconsin1 papers (2020–2020)John E. Levine · University of Oklahoma Health Sciences Center1 papers (2020–2020)Christopher C. Dvorak · National Institute Of Blood Disease and Bone Marrow Transplantation1 papers (2020–2020)Jacek Toporski · Skåne University Hospital1 papers (2020–2020)Kirk R. Schultz · University of British Columbia1 papers (2020–2020)Wing Leung · KK Women's and Children's Hospital1 papers (2020–2020)Brian D. Friend · Medical College of Wisconsin1 papers (2020–2020)Carrie L. Kitko · Vanderbilt University Medical Center1 papers (2020–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hematology · Public Health, Environmental and Occupational Health →